Tomohiko Ono
- Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertensionBy Yuichi Tamura, Masataka Kuwana, Kenji Inoue, Tomohiko Ono, Makoto Takei, Tsunehisa Yamamoto, Masaharu Kataoka, Motoaki Sano, Toru Satoh and Keiichi FukudaYuichi Tamura1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanMasataka Kuwana2Department of Rheumatology, Keio University School of Medicine, Tokyo, JapanKenji Inoue3Department of Cardiology, Juntendo University Nerima Hospital, Tokyo, JapanTomohiko Ono1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanMakoto Takei1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanTsunehisa Yamamoto1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanMasaharu Kataoka4Department of Cardiology, Kyorin University School of Medicine, Tokyo, JapanMotoaki Sano1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanToru Satoh4Department of Cardiology, Kyorin University School of Medicine, Tokyo, JapanKeiichi Fukuda1Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
- EPITOME-4, a phase 3b study evaluating a new formulation of epoprostenol sodium in pulmonary arterial hypertension following switch from Flolan®By Yuichi Tamura, Tomohiko Ono, Keiichi Fukuda, Toru Satoh and Shigetake SasayamaYuichi Tamura1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanTomohiko Ono1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanKeiichi Fukuda1Department of Cardiology, Keio University School of Medicine, Tokyo, JapanToru Satoh2Department of Cardiology, Kyorin University School of Medicine, Tokyo, JapanShigetake Sasayama3Department of Life and Medical Science, Doshisha University, Kyoto, Japan
- Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertensionBy Yuichi Tamura, Mai Kimura, Makoto Takei, Tomohiko Ono, Masataka Kuwana, Toru Satoh, Keiichi Fukuda and Marc HumbertArticle | Published in 2015 in European Respiratory JournalYuichi Tamura1Dept of Cardiology, Keio University School of Medicine, Tokyo, Japan2Faculté de Médecine, Université Paris-Sud, Le Kremlin Bicêtre, France3Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France4Inserm UMR_S 999, LabExLERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, FranceMai Kimura1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMakoto Takei1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanTomohiko Ono1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMasataka Kuwana5Dept of Allergy and Rheumatology, Nippon Medical School, Tokyo, JapanToru Satoh6Dept of Cardiology, Kyorin University School of Medicine, Tokyo, JapanKeiichi Fukuda1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMarc Humbert2Faculté de Médecine, Université Paris-Sud, Le Kremlin Bicêtre, France3Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France4Inserm UMR_S 999, LabExLERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
- Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertensionBy Yuichi Tamura, Mai Kimura, Makoto Takei, Tomohiko Ono, Masataka Kuwana, Toru Satoh, Keiichi Fukuda and Marc HumbertYuichi Tamura1Dept of Cardiology, Keio University School of Medicine, Tokyo, Japan2Faculté de Médecine, Université Paris-Sud, Le Kremlin Bicêtre, France3Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France4Inserm UMR_S 999, LabExLERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, FranceMai Kimura1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMakoto Takei1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanTomohiko Ono1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMasataka Kuwana5Dept of Allergy and Rheumatology, Nippon Medical School, Tokyo, JapanToru Satoh6Dept of Cardiology, Kyorin University School of Medicine, Tokyo, JapanKeiichi Fukuda1Dept of Cardiology, Keio University School of Medicine, Tokyo, JapanMarc Humbert2Faculté de Médecine, Université Paris-Sud, Le Kremlin Bicêtre, France3Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France4Inserm UMR_S 999, LabExLERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.